(919) 964 3638

Speedwell Bio

Technology Platforms to Support Drug Discovery and Diagnostic Testing

Clinical Support

Clinically validated multiplex diagnostic assays

Research Support

Customized molecular assays to support client research goals

Drug Discovery

Customized cellular/phenotypic assays


We are a Biotechnology Research Company

Our main goal is to develop customized fit-for-purpose assays that best serve a wide range of client needs in molecular biology. The team consists of a blend of experts with both academic and industry experience. Our company started in 2020 with funding from the CARES Act to develop a one-step RT-PCR assay for COVID testing in low resource/Point-of-Care environments. This work led us to develop relationships with diagnostic experts equipped with CLIA labs and the ability to carry out clinical validation of our assays. In parallel, we have also developed a wide range of oncology assays and have formed strong partnerships with labs at both UNC-Chapel Hill and Duke where we have ongoing collaborative projects in both oncology drug discovery and basic research. Our company is nimble and can switch priorities quickly at client’s request while maintaining low costs.

Our Research

Explore Our Main Services

Pathogen Molecular Assay List
Copy Number Assays
Single Nucleotide Polymorphism Assays
Bisulfite-free, qPCR based DNA methylation assessment
Transgenic Mouse Genotyping
Genomic DNA Reference Materials
Proprietary Technology

One-Step qPCR/RT-qPCR


  • All Included except samples
  • Individualized aliquot
  • Cost-Effective
  • Labor and Time Efficient
  • Ideal for Field transportation and Test


  • Pathogen Detection
  • SNP Identification
  • Copy Number Detection
  • Transgenic Mouse Genotyping

our Service

Drug Discovery And Assay Development

We work with pharmaceuticals and clinical laboratories for drug discovery support and clinical molecular diagnostic assay development

Molecular biomarker identification and development
Genotyping assays
Analysis of microscale, hard-to-obtain clinical samples
Customized assay development
0 +
Awards Winning
0 +
Our Equipments
0 +
Field Expertise
0 +
Industry Expertise
Our Expert

Meet Our Team

Fangping Zhao


John is the Scientific Director at Speedwell Bio. He spent 23 years in R&D at GlaxoSmithKline, the last 4 years as Director of the Experimental Biology group in RTP, participating in and leading projects in drug discovery, phenotypic assay development, and target validation. John received his bachelor’s degree from the University of Virginia, his Ph.D. from University of Minnesota, and his postdoctoral training in genetics at the University of California, Berkeley
John Moore

Scientific Director

Deepak Kumar

Scientific Advisor


Subscribe & Get More Information